Karius
San Francisco, US · Founded 2014 · 216 employees on LinkedIn · 10 known investors
Find your way into Karius
Sign up to see every warm intro you have to Karius
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Karius team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Karius is a company that provides microbial cell-free DNA (mcfDNA) metagenomic sequencing services for research and clinical applications. The company runs an Investigator-Initiated Studies grants program to support independent research on diagnostic testing outcomes, health economics, and fundamental science related to its sequencing technology.
Founders & leadership
Investors · 10
How we know: 5AM Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: HBM Healthcare Investments's portfolio page · Not right? Tell us
How we know: HBM Partners's portfolio page · Not right? Tell us
How we know: Khosla Ventures's portfolio page · a partner's Signal profile · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Lightspeed Venture Partners's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Seventure Partners's portfolio page · Not right? Tell us
Funding
SEC filings, press & company announcements$165M disclosed across 1 round · 2020
- $165MraisedFeb 2020 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
Related companies · 1
Companies working in the same space as Karius.
In the news
Frequently asked questions
- What does Karius do?
- Karius is a company that provides microbial cell-free DNA (mcfDNA) metagenomic sequencing services for research and clinical applications. The company runs an Investigator-Initiated Studies grants program to support independent research on diagnostic testing outcomes, health economics, and fundamental science related to its sequencing technology.
- Who are Karius's investors?
- Karius's investors include 5AM Ventures, DCVC (Data Collective), HBM Healthcare Investments, HBM Partners, Khosla Ventures, Lightspeed Venture Partners, Seventure Partners, SoftBank Vision Fund and 2 more.
- How much funding has Karius raised?
- Karius has disclosed $165M raised across 1 round.
- Where is Karius headquartered?
- Karius is headquartered in San Francisco, US.





.png)
